Ca -125 (ovarian Cancer Monitor)

CA 125 (Ovarian Cancer Monitor), Serum assessment measures the level of cancer antigen 125, a protein often elevated in ovarian cancer and some other conditions. It is widely used as a tumor marker to monitor disease progression, response to treatment, and recurrence in individuals with ovarian cancer.

Who should get CA 125 (Ovarian Cancer Monitor), Serum test done?

• Women undergoing treatment for ovarian cancer

• Patients in follow-up care after therapy completion

• Individuals with strong family history or genetic predisposition for ovarian cancer (as part of a broader evaluation)

• Women with persistent unexplained pelvic symptoms under specialist advice

Why consider CA 125 (Ovarian Cancer Monitor), Serum test?

While not specific enough for general cancer screening, CA 125 testing is valuable in monitoring women already diagnosed with ovarian cancer. Rising levels may indicate disease recurrence, while falling levels suggest positive response to therapy. Elevated results can also be seen in benign conditions such as endometriosis, pelvic inflammatory disease, or even pregnancy, so interpretation requires medical expertise.

More information about CA 125 (Ovarian Cancer Monitor), Serum test

This test alone cannot confirm or rule out ovarian cancer but is highly useful in monitoring and follow-up. Doctors often combine it with imaging studies like ultrasound or CT scans for accuracy. It is also part of long-term surveillance in women at high risk of ovarian malignancy.